1. Home
  2. ARVN vs CTOS Comparison

ARVN vs CTOS Comparison

Compare ARVN & CTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • CTOS
  • Stock Information
  • Founded
  • ARVN 2015
  • CTOS 1988
  • Country
  • ARVN United States
  • CTOS United States
  • Employees
  • ARVN N/A
  • CTOS N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • CTOS Diversified Commercial Services
  • Sector
  • ARVN Health Care
  • CTOS Consumer Discretionary
  • Exchange
  • ARVN Nasdaq
  • CTOS Nasdaq
  • Market Cap
  • ARVN 1.2B
  • CTOS 1.1B
  • IPO Year
  • ARVN 2018
  • CTOS N/A
  • Fundamental
  • Price
  • ARVN $7.02
  • CTOS $4.22
  • Analyst Decision
  • ARVN Buy
  • CTOS Buy
  • Analyst Count
  • ARVN 13
  • CTOS 4
  • Target Price
  • ARVN $34.42
  • CTOS $5.88
  • AVG Volume (30 Days)
  • ARVN 3.5M
  • CTOS 750.1K
  • Earning Date
  • ARVN 05-06-2025
  • CTOS 03-04-2025
  • Dividend Yield
  • ARVN N/A
  • CTOS N/A
  • EPS Growth
  • ARVN N/A
  • CTOS N/A
  • EPS
  • ARVN N/A
  • CTOS N/A
  • Revenue
  • ARVN $263,399,999.00
  • CTOS $1,802,280,000.00
  • Revenue This Year
  • ARVN N/A
  • CTOS $5.31
  • Revenue Next Year
  • ARVN $7.99
  • CTOS $8.22
  • P/E Ratio
  • ARVN N/A
  • CTOS N/A
  • Revenue Growth
  • ARVN 235.54
  • CTOS N/A
  • 52 Week Low
  • ARVN $6.88
  • CTOS $3.03
  • 52 Week High
  • ARVN $41.34
  • CTOS $6.27
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 23.50
  • CTOS 37.88
  • Support Level
  • ARVN $8.51
  • CTOS $4.65
  • Resistance Level
  • ARVN $9.17
  • CTOS $5.26
  • Average True Range (ATR)
  • ARVN 0.55
  • CTOS 0.22
  • MACD
  • ARVN -0.05
  • CTOS -0.04
  • Stochastic Oscillator
  • ARVN 5.24
  • CTOS 1.89

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About CTOS Custom Truck One Source Inc.

Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.

Share on Social Networks: